Treatment with biological products for chronic rhinosinusitis with nasal polyp
Open Access
- 10 September 2023
- journal article
- research article
- Published by Korean Medical Association in Journal of the Korean Medical Association
- Vol. 66 (9) , 532-536
Abstract
Background: Chronic rhinosinusitis (CRS) is further classified as CRS with nasal polyp and CRS without nasal polyp. It is also divided into type 2 and none-type 2 by immunological endotype. Nowadays, novel biological products targeting type 2 inflammation are developed and used for the treatment of CRS with nasal polyp.Current Concepts: Dupilumab, which inhibits interleukin-4 and interleukin-13, and omalizumab, which targets immunoglobulin E, were recently approved and are currently being used as the treatment regimen for patients with recurrent CRS with nasal polyp in Korea. Many studies demonstrated enough effects of both biological products on nasal symptoms, including smell, quality of life, and polyp size. The indication of biological products is refractory CRS with nasal polyp with severe symptoms even after endoscopic sinus surgery. However, the main drawback of these biological products is a high cost since they are non-reimbursement regimens as defined by Korean national health insurance.Discussion and Conclusion: Further research on the use of dupilumab and omalizumab in Korean patients will be needed because the Korean CRS endotype, which is characterized by less-type-2 CRS, is different from Western CRS endotypes. Additionally, investigations on the comparison of efficacy among various biological products are essential to prescribe the most appropriate biological products depending on the patients’ endotypes.Keywords
Funding Information
- Seoul National University Hospital (04-2019-0260)
This publication has 22 references indexed in Scilit:
- Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian populationAsia Pacific Allergy, 2017
- Real-life study showing uncontrolled rhinosinusitis after sinus surgery in a tertiary referral centreAllergy, 2016
- Chronic Rhinosinusitis with Nasal PolypsThe Journal of Allergy and Clinical Immunology: In Practice, 2016
- Prevalence and Risk Factors of Chronic Rhinosinusitus, Allergic Rhinitis, and Nasal Septal DeviationJAMA Otolaryngology–Head & Neck Surgery, 2016
- Does Eosinophilic Inflammation Affect the Outcome of Endoscopic Sinus Surgery in Chronic Rhinosinusitis in Koreans?American Journal of Rhinology & Allergy, 2013
- The association between bacterial colonization and inflammatory pattern in Chinese chronic rhinosinusitis patients with nasal polypsAllergy, 2011
- Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult ChineseJournal of Allergy and Clinical Immunology, 2009
- Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus diseaseJournal of Allergy and Clinical Immunology, 2008
- Histological and immunological features of non‐eosinophilic nasal polypsOtolaryngology–Head and Neck Surgery, 2007
- Differentiation of chronic sinus diseases by measurement of inflammatory mediatorsAllergy, 2006